Article

Identification of 6-(piperazin-1-yl)-1,3,5-triazine as a chemical scaffold with broad anti-schistosomal activities

2020-11-13

Abstract excerpt

<h4>Background: </h4> Schistosomiasis, caused by infection with blood fluke schistosomes, is a neglected tropical disease of considerable importance in resource-poor communities throughout the developing world. In the absence of an immunoprophylactic vaccine and due to over-reliance on a single chemotherapy (praziquantel), schistosomiasis control is at risk should drug insensitive schistosomes develop. In this con...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: f5ea69c5-491d-50ae-9e15-a9cb6fb44205
DOI: 10.12688/wellcomeopenres.16069.2

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Identification of 6-(piperazin-1-yl)-1,3,5-triazine as a chemical scaffold with broad anti-schistosomal activitiesDOI 10.12688/wellcomeopenres.16069.2Read

Screening and Phenotypical Characterization of Schistosoma mansoni Histone Deacetylase 8 (SmHDAC8) Inhibitors as Multistage Antischistosomal Agents.Semantic proximity Read

The repositioning of epigenetic probes/inhibitors identifies new anti-schistosomal lead compounds and chemotherapeutic targetsSemantic proximity Read

<i>Schistosoma mansoni</i> lysine specific demethylase 1 (SmLSD1) is a druggable target involved in parasite survival, oviposition and stem cell proliferationSemantic proximity Read

Chemical modulation of Schistosoma mansoni lysine specific demethylase 1 (SmLSD1) induces wide-scale biological and epigenomic changesSemantic proximity Read

Pharmacological inhibition of lysine-specific demethylase 1 (LSD1) induces global transcriptional deregulation and ultrastructural alterations that impair viability in <i>Schistosoma mansoni</i>Semantic proximity Read

The repositioning of epigenetic probes/inhibitors identifies new anti-schistosomal lead compounds and chemotherapeutic targetsSemantic proximity Read

Drugging the Schistosome Zinc-Dependent HDACs: Current Progress and Future PerspectivesSemantic proximity Read

Dual Strategy to Design New Agents Targeting Schistosoma mansoni: Advancing Phenotypic and SmCB1 Inhibitors for Improved Efficacy.Semantic proximity Read

Structure-Reactivity Relationships on Substrates and Inhibitors of the Lysine Deacylase Sirtuin 2 from Schistosoma Mansoni (SmSirt2)Semantic proximity Read

Rational approach to drug discovery for human schistosomiasisSemantic proximity Read

Highly accurate protein structure prediction-based virtual docking pipeline accelerating the identification of anti-schistosomal compoundsSemantic proximity Read

Quinoxaline-Based Anti-Schistosomal Compounds Have Potent Anti-Malarial ActivitySemantic proximity Read